NCT01701141 Depression and Dopamine Transporter Function Study Using C-11 Altropane Status COMPLETED Phase N/A
NCT01699490 Role of Inflammation Factors and Insulin Resistance in Major Depressive Disorder Status UNKNOWN Phase PHASE4
NCT01696617 Aripiprazole (Abilify®) as an Adjunctive Treatment for Inadequate Response in Major Depressive Disorder Status COMPLETED Phase PHASE4
NCT01692574 Treatment for Depressed, Obese Individuals at Risk for Cardiovascular Disease (CVD) Status COMPLETED Phase NA
NCT01685294 Effectiveness of Interpersonal Psychotherapy (IPT) for Men and Women Prisoners With Major Depression Status COMPLETED Phase PHASE3
NCT01684163 Efficacy and Safety of GLYX-13 in Subjects With Inadequate/Partial Response to Antidepressants Status COMPLETED Phase PHASE2
NCT01682785 Incidence of Metabolic Syndrome and Thyroid Dysfunction in Patients With Major Depressive Disorder Status UNKNOWN Phase N/A
NCT01671124 The Study of Antidepressant Properties and Safety of Fer-01(Soline®) on the Patients With Depression Status UNKNOWN Phase N/A
NCT01670279 Phase 1 Study to Assess the Safety/Tolerability of Brexpiprazole as Adjunctive Therapy in Elderly Subjects With Major Depressive Disorder Status COMPLETED Phase PHASE1
NCT01667926 Ketamine Versus Placebo for Treatment Resistant Major Depressive Disorder Status COMPLETED Phase NA
NCT01655706 Canadian Biomarker Integration Network for Depression Study Status COMPLETED Phase PHASE3
NCT01650740 Study of Placebo Without Deception Versus Standard Antidepressant for Major Depressive Disorder Status TERMINATED Phase NA
NCT01640483 Differential Efficacy of Supportive and Interpretative Psychodynamic Techniques for Dependent and Self-critical Depressive Patients Status COMPLETED Phase NA
NCT01640080 A Study of the Efficacy of Intravenous Esketamine in Adult Patients With Treatment-Resistant Depression Status COMPLETED Phase PHASE2
NCT01633437 Oral Tyramine Pressor Response Study of CX157 Tablets in Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT01627782 A Study of Ketamine in Patients With Treatment-resistant Depression Status COMPLETED Phase PHASE2